-
EP3901260
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3901260
| EP3901260 - CORONAVIRUS VACCINE [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 22.07.2022 Database last updated on 30.10.2024 | |
| Former | Request for examination was made Status updated on 24.09.2021 | Most recent event Tooltip | 24.09.2024 | New entry: Application deemed to be withdrawn: despatch of communication + time limit | Applicant(s) | For all designated states BioNTech SE An der Goldgrube 12 55131 Mainz / DE | [2021/52] |
| Former [2021/43] | For all designated states BioNTech RNA Pharmaceuticals GmbH An der Goldgrube 12 55131 Mainz / DE | Inventor(s) | 01 /
SAHIN, Ugur c/o BioNTech RNA Pharmaceuticals GmbH An der Goldgrube 12 55131 Mainz / DE | 02 /
GÜLER, Alptekin c/o BioNTech RNA Pharmaceuticals GmbH An der Goldgrube 12 55131 Mainz / DE | 03 /
KUHN, Andreas c/o BioNTech RNA Pharmaceuticals GmbH An der Goldgrube 12 55131 Mainz / DE | 04 /
MUIK, Alexander c/o BioNTech RNA Pharmaceuticals GmbH An der Goldgrube 12 55131 Manz / DE | 05 /
VOGEL, Annette c/o BioNTech RNA Pharmaceuticals GmbH An der Goldgrube 12 55131 Mainz / DE | 06 /
WALZER, Kerstin c/o BioNTech RNA Pharmaceuticals GmbH An der Goldgrube 12 55131 Mainz / DE | 07 /
WITZEL, Sonja c/o TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH Freiligrathstr. 12 55131 Mainz / DE | 08 /
HEIN, Stephanie c/o BioNTech RNA Pharmaceuticals GmbH An der Goldgrube 12 55131 Mainz / DE | 09 /
TÜRECI, Özlem c/o BioNTech RNA Pharmaceuticals GmbH An der Goldgrube 12 55131 Mainz / DE | [2021/43] | Representative(s) | Schnappauf, Georg ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE | [2021/43] | Application number, filing date | 21168938.5 | 16.04.2021 | [2021/43] | Priority number, date | WO2020EP61239 | 22.04.2020 Original published format: PCT/EP2020/061239 | WO2020EP66968 | 18.06.2020 Original published format: PCT/EP2020/066968 | WO2020EP68174 | 26.06.2020 Original published format: PCT/EP2020/068174 | WO2020EP69805 | 13.07.2020 Original published format: PCT/EP2020/069805 | WO2020EP71733 | 31.07.2020 Original published format: PCT/EP2020/071733 | WO2020EP71839 | 03.08.2020 Original published format: PCT/EP2020/071839 | WO2020EP73668 | 24.08.2020 Original published format: PCT/EP2020/073668 | WO2020EP81544 | 09.11.2020 Original published format: PCT/EP2020/081544 | WO2020EP81981 | 12.11.2020 Original published format: PCT/EP2020/081981 | WO2020EP82601 | 18.11.2020 Original published format: PCT/EP2020/082601 | WO2020EP82989 | 20.11.2020 Original published format: PCT/EP2020/082989 | WO2020EP83435 | 25.11.2020 Original published format: PCT/EP2020/083435 | WO2020EP84342 | 02.12.2020 Original published format: PCT/EP2020/084342 | WO2020EP85145 | 08.12.2020 Original published format: PCT/EP2020/085145 | WO2020EP85653 | 10.12.2020 Original published format: PCT/EP2020/085653 | WO2020EP87844 | 23.12.2020 Original published format: PCT/EP2020/087844 | WO2021EP50027 | 04.01.2021 Original published format: PCT/EP2021/050027 | WO2021EP50874 | 15.01.2021 Original published format: PCT/EP2021/050874 | WO2021EP50875 | 15.01.2021 Original published format: PCT/EP2021/050875 | WO2021EP51772 | 26.01.2021 Original published format: PCT/EP2021/051772 | WO2021EP52572 | 03.02.2021 Original published format: PCT/EP2021/052572 | WO2021EP52716 | 04.02.2021 Original published format: PCT/EP2021/052716 | WO2021EP54622 | 24.02.2021 Original published format: PCT/EP2021/054622 | [2021/43] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3901260 | Date: | 27.10.2021 | Language: | EN | [2021/43] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 16.09.2021 | Classification | IPC: | C12N15/11, A61K39/215, A61K45/06, C12N15/00, C12N15/10, C07H21/00, C07H21/02 | [2021/43] | CPC: |
A61K39/12 (EP,IL,KR,US);
A61K48/0066 (CN,IL,KR,US);
C12N15/11 (EP,IL,KR,US);
C12N15/113 (CN,IL);
A61K39/215 (GB,IL,US);
A61K31/7088 (IL,US);
A61K31/7105 (EP,CN,GB,IL,US);
A61K31/711 (EP,CN,IL,US);
A61K31/7115 (EP,IL,US);
A61K31/712 (EP,CN,IL,US);
A61K38/00 (EP,IL,US);
A61K39/0008 (EP,IL);
A61K39/0011 (EP,GB,IL,US);
A61K39/4644 (KR);
A61K45/06 (EP,IL,KR);
A61K47/44 (IL);
A61K48/0025 (EP,IL);
A61K48/0033 (IL,US);
A61K9/0019 (EP,IL,US);
A61K9/127 (GB,IL);
A61K9/1271 (GB,IL,US);
A61K9/5123 (CN,IL,KR,US);
A61K9/5146 (CN,IL,KR,US);
A61P31/14 (EP,IL,KR,US);
A61P35/00 (EP,IL,KR,US);
A61P37/02 (IL);
B82Y5/00 (IL,US);
C12N15/67 (EP,IL,US);
C12N15/88 (EP,IL,KR,US);
C12N7/00 (IL,US);
C12P19/34 (EP,IL,US);
C12P21/02 (EP,IL);
A61K2039/53 (EP,IL,KR,US);
A61K2039/54 (IL,US);
A61K2039/545 (EP,IL,KR,US);
A61K2039/55555 (EP,IL,KR,US);
A61K2121/00 (KR);
A61K2300/00 (IL);
C12N2310/335 (CN,IL);
C12N2770/18022 (IL,US);
C12N2770/18034 (IL,US);
C12N2770/18071 (IL,US);
| C-Set: |
A61K31/7105, A61K2300/00 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/43] | Extension states | BA | 26.04.2022 | ME | 26.04.2022 | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | CORONAVIRUSIMPFSTOFF | [2021/43] | English: | CORONAVIRUS VACCINE | [2021/43] | French: | VACCIN CONTRE LE CORONAVIRUS | [2021/43] | Examination procedure | 16.04.2021 | Examination requested [2021/43] | 05.04.2022 | Observations by third parties | 26.04.2022 | Amendment by applicant (claims and/or description) | 26.07.2022 | Despatch of a communication from the examining division (Time limit: M04) | 28.11.2022 | Reply to a communication from the examining division | 24.02.2023 | Despatch of a communication from the examining division (Time limit: M06) | 05.12.2023 | Reply to a communication from the examining division | 06.05.2024 | Despatch of a communication from the examining division (Time limit: M04) | 23.09.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 05.12.2023 | Request for further processing filed | 05.12.2023 | Full payment received (date of receipt of payment) Request granted | 13.12.2023 | Decision despatched | Fees paid | Renewal fee | 20.04.2023 | Renewal fee patent year 03 | 22.04.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2016176330 (UNIV PENNSYLVANIA [US], et al); | [Y]WO2018081480 (ACUITAS THERAPEUTICS INC [CA]); | [A]WO2018081318 (US HEALTH [US], et al); | [AP]WO2020198337 (OHIO STATE INNOVATION FOUNDATION [US]); | [E]WO2021154763 (MODERNATX INC [US]); | [E]WO2021156267 (CUREVAC AG [DE]); | [E]WO2021163365 (US HEALTH [US], et al); | Examination | WO2009127060 | by applicant | WO2011015347 | WO2016005324 | WO2017060314 | other | WO2009127060 |